BioCentury | Apr 1, 2019
Clinical News

Apexigen's CD40 agonist shows response in pancreatic cancer

...The study was conducted by the Parker Institute for Cancer Immunotherapy in collaboration with the Cancer Research Institute...
BioCentury | Dec 1, 2018
Product Development

Cell therapy momentum at ASH

...expressed in dendritic cells (DCs) Acute myelogenous leukemia (AML) Preclinical 3693 Other combinations Fred Hutchinson Cancer Research Institute...
BioCentury | Jun 16, 2018
Product Development

NSCLC disrupted

...time, have lost it,” said Jill O’Donnell-Tormey, CEO and director of scientific affairs for the Cancer Research Institute...
...and now people who were thinking that they had time, have lost it.” Jill O’Donnell-Tormey, Cancer Research Institute...
...City, Calif. AstraZeneca plc (NYSE:AZN; LSE:AZN), London, U.K. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Institute...
BioCentury | Apr 20, 2018
Product Development

Lessons from the ECHO chamber

...from Eli Lilly and Co. (NYSE:LLY). Source: ClinicalTrials.gov Beyond IDO1, a December report from the Cancer Research Institute...
...new technologies and science are being built and evaluated on an old structure.” Vanessa Lucey, Cancer Research Institute...
...most likely to succeed. Companies and Institutions Mentioned Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Institute...
BioCentury | Apr 6, 2018
Preclinical News

Tumor immune microenvironment could predict prognosis

...A team led by researchers from the Cancer Research Institute, Institute for Systems Biology and Sage Bionetworks have...
...mutations in 276 genes that regulate DDR pathways (see BioCentury Extra, April 5) . Elizabeth S. Eaton Cancer Research Institute Institute...
BioCentury | Mar 2, 2018
Company News

BMS partners with Yale Cancer Center as part of immuno-oncology network

Bristol-Myers Squibb Co. (NYSE:BMY) partnered with the Yale Cancer Center at Yale School of Medicine to perform translational immuno-oncology research as part of BMS’s International Immuno-Oncology Network (II-ON). BMS formed the network in 2012 to...
BioCentury | Jan 31, 2018
Distillery Therapeutics

Cancer

...testing for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Apexigen Inc., Bristol-Myers Squibb Co., Cancer Research Institute...
BioCentury | Jan 26, 2018
Finance

Tmunity’s A team

...the UPenn’s Perelman School of Medicine and director of translational research at its Abramson Family Cancer Research Institute...
BioCentury | Dec 7, 2017
Clinical News

Cancer Research Institute publishes analysis of immuno-oncology field

...51 agents owned by 22 U.S. companies and a smaller number in other countries combined. Mary Romeo Cancer Research Institute Merck...
BioCentury | Sep 29, 2017
Company News

Cancer Research, Parker Institute partner to test I-O combos for pancreatic cancer

...expected to conclude in 2022, but Shalabi said initial results could be presented next year. Cancer Research Institute...
...NYSE:BMY), New York, N.Y. Apexigen Inc. , San Carlos, Calif. Business: Cancer Mary Romeo APX005M Opdivo Apexigen Inc. Bristol-Myers Squibb Co. Cancer Research Institute Parker...
Items per page:
1 - 10 of 87
BioCentury | Apr 1, 2019
Clinical News

Apexigen's CD40 agonist shows response in pancreatic cancer

...The study was conducted by the Parker Institute for Cancer Immunotherapy in collaboration with the Cancer Research Institute...
BioCentury | Dec 1, 2018
Product Development

Cell therapy momentum at ASH

...expressed in dendritic cells (DCs) Acute myelogenous leukemia (AML) Preclinical 3693 Other combinations Fred Hutchinson Cancer Research Institute...
BioCentury | Jun 16, 2018
Product Development

NSCLC disrupted

...time, have lost it,” said Jill O’Donnell-Tormey, CEO and director of scientific affairs for the Cancer Research Institute...
...and now people who were thinking that they had time, have lost it.” Jill O’Donnell-Tormey, Cancer Research Institute...
...City, Calif. AstraZeneca plc (NYSE:AZN; LSE:AZN), London, U.K. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Institute...
BioCentury | Apr 20, 2018
Product Development

Lessons from the ECHO chamber

...from Eli Lilly and Co. (NYSE:LLY). Source: ClinicalTrials.gov Beyond IDO1, a December report from the Cancer Research Institute...
...new technologies and science are being built and evaluated on an old structure.” Vanessa Lucey, Cancer Research Institute...
...most likely to succeed. Companies and Institutions Mentioned Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Institute...
BioCentury | Apr 6, 2018
Preclinical News

Tumor immune microenvironment could predict prognosis

...A team led by researchers from the Cancer Research Institute, Institute for Systems Biology and Sage Bionetworks have...
...mutations in 276 genes that regulate DDR pathways (see BioCentury Extra, April 5) . Elizabeth S. Eaton Cancer Research Institute Institute...
BioCentury | Mar 2, 2018
Company News

BMS partners with Yale Cancer Center as part of immuno-oncology network

Bristol-Myers Squibb Co. (NYSE:BMY) partnered with the Yale Cancer Center at Yale School of Medicine to perform translational immuno-oncology research as part of BMS’s International Immuno-Oncology Network (II-ON). BMS formed the network in 2012 to...
BioCentury | Jan 31, 2018
Distillery Therapeutics

Cancer

...testing for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Apexigen Inc., Bristol-Myers Squibb Co., Cancer Research Institute...
BioCentury | Jan 26, 2018
Finance

Tmunity’s A team

...the UPenn’s Perelman School of Medicine and director of translational research at its Abramson Family Cancer Research Institute...
BioCentury | Dec 7, 2017
Clinical News

Cancer Research Institute publishes analysis of immuno-oncology field

...51 agents owned by 22 U.S. companies and a smaller number in other countries combined. Mary Romeo Cancer Research Institute Merck...
BioCentury | Sep 29, 2017
Company News

Cancer Research, Parker Institute partner to test I-O combos for pancreatic cancer

...expected to conclude in 2022, but Shalabi said initial results could be presented next year. Cancer Research Institute...
...NYSE:BMY), New York, N.Y. Apexigen Inc. , San Carlos, Calif. Business: Cancer Mary Romeo APX005M Opdivo Apexigen Inc. Bristol-Myers Squibb Co. Cancer Research Institute Parker...
Items per page:
1 - 10 of 87